Skip to main content
MDCXW logo

MDCXW · Medicus Pharma Ltd. · Shareholders & Ownership

Track MDCXW — free
$0.24 At close · Oct 27
Market Cap
$3.10M
Shares
1.26M
Volume · Oct 27 674 Avg daily vol (3M) 1291

Every disclosed holder of MDCXW in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.

Who Owns MDCXW

13F quarter Jun 30, 2026; this listing alone: insiders and shares outstanding are issuer-wide, so they are left out

No chart: shares outstanding cannot be set against these holders.

Holder group Shares % Out
Institutional (13F) 111,203 —
Insiders (Forms 3, 4, 5) 0 —
13D/G-only blocks 0 —
Registered funds (N-PORT, not summed) 0 —

% Out is unavailable: shares outstanding is an issuer-wide count, not one listing's.

13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.

Holders of MDCXW

# Holder Shares
1
ARMISTICE CAPITAL, LLC
13F CIK 1601086 · Registered investment adviser · Jun 30, 2026
60,600
2
Anson Funds Management LP
13F CIK 1491072 · Registered investment adviser · Jun 30, 2026
42,400
3
Connective Capital Management, LLC
13F CIK 1543568 · Registered investment adviser · Jun 30, 2026
6,000
4
UBS Group AG
13F CIK 1610520 · Bank · Jun 30, 2026
2,203

Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.

Key facts CIK 1997296 CUSIP 58471K202 Visit website Investor relations